144 related articles for article (PubMed ID: 24961337)
1. [Efficacy of intravenous iloprost (Ilomedin®) in salvage of the only extremity in a patient with thrombangiitis obliterans].
Gaĭsin IR; Bagautdinova ZR; Trukhina AA; Burlaeva NA; Gibadullina LR; Timonin DV; Smirnov IA; maksimov NI
Angiol Sosud Khir; 2014; 20(2):150-6. PubMed ID: 24961337
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of intravenous ilomedin infusion and smoking cessation in the treatment of acutely symptomatic Buerger disease.
Spanos K; Georgiou E; Saleptsis V; Athanasoulas A; Sakkas L; Giannoukas AD
Angiology; 2015 Feb; 66(2):114-7. PubMed ID: 24366824
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.
Melillo E; Grigoratos C; Sanctis FD; Spontoni P; Nuti M; Dell'Omodarme M; Ferrari M; Balbarini A
Angiology; 2015 Jul; 66(6):531-8. PubMed ID: 25005765
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
Galyfos G; Kerasidis S; Kastrisios G; Giannakakis S; Sachmpazidis I; Anastasiadou C; Geropapas G; Papapetrou A; Papacharalampous G; Maltezos C
Vasa; 2017 Oct; 46(6):471-475. PubMed ID: 28753096
[TBL] [Abstract][Full Text] [Related]
5. [Ilomedin (Iloprost) and Buerger disease].
Benthin NP
Ugeskr Laeger; 1995 Sep; 157(36):4946-7. PubMed ID: 7545838
[TBL] [Abstract][Full Text] [Related]
6. Use of duplex ultrasonography in the treatment of thromboangiitis obliterans with iloprost.
Noël B; Panizzon RG
Dermatology; 2004; 208(3):238-40. PubMed ID: 15118378
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment for Buerger's disease.
Cacione DG; Macedo CR; do Carmo Novaes F; Baptista-Silva JC
Cochrane Database Syst Rev; 2020 May; 5(5):CD011033. PubMed ID: 32364620
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment for Buerger's disease.
Cacione DG; Macedo CR; Baptista-Silva JC
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011033. PubMed ID: 26967103
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment for Buerger's disease.
Cacione DG; Baptista-Silva JC; Macedo CR
Cochrane Database Syst Rev; 2016 Feb; 2():CD011033. PubMed ID: 26828199
[TBL] [Abstract][Full Text] [Related]
10. Iloprost: new indication. Not adequately assessed.
Prescrire Int; 1999 Apr; 8(40):49-50. PubMed ID: 10848061
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.
Bozkurt AK; Köksal C; Demirbas MY; Erdoğan A; Rahman A; Demirkiliç U; Ustünsoy H; Metin G; Yillik L; Onol H; Cinar B; Karaçelik M; Erdinç I; Bolcal C; Sayin AG;
Int Angiol; 2006 Jun; 25(2):162-8. PubMed ID: 16763533
[TBL] [Abstract][Full Text] [Related]
12. Compartment syndrome as a rare complication of iloprost infusion for peripheral vascular disease.
Thomas GP; Kadam S; Mohammed M; Andrews BT
Ann Vasc Surg; 2011 May; 25(4):555.e11-2. PubMed ID: 21549925
[TBL] [Abstract][Full Text] [Related]
13. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.
Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):300-7. PubMed ID: 9610341
[TBL] [Abstract][Full Text] [Related]
14. [Modern aspects of diagnostics and treatment for thromboangiitis obliterans].
Abyshov NS; Zakirdzhaev EA; Aliev ZM
Khirurgiia (Mosk); 2009; (2):75-9. PubMed ID: 19368048
[No Abstract] [Full Text] [Related]
15. A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans.
Shima N; Akiyama Y; Yamamoto S; Kokuzawa A; Nagatani K; Iwamoto M; Matsubara D; Kawai S; Sato K; Minota S
Intern Med; 2020 Feb; 59(3):439-443. PubMed ID: 31588083
[TBL] [Abstract][Full Text] [Related]
16. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Blanco-Sánchez G; Rodríguez-Mateos ME; Linares-Barrios M
Dermatol Ther; 2015; 28(3):135-9. PubMed ID: 25649782
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman.
Lopalco G; Iannone F; Rigante D; Vitale A; Mancini ME; Covelli M; Lapadula G; Cantarini L
Reumatismo; 2015 Jun; 67(1):17-20. PubMed ID: 26150270
[TBL] [Abstract][Full Text] [Related]
18. [Lower limb omental implantation in patients with obliterative thrombangiitis].
Vachev AN; Mikhaĭlov MS; Novozhilov AV; Chernovalov DA
Khirurgiia (Mosk); 2011; (12):19-22. PubMed ID: 22433519
[TBL] [Abstract][Full Text] [Related]
19. Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.
Uyanık SA; Öğüşlü U; Aminu IS; Yılmaz B; Çevik H; Atlı E; Gümüş B
AJR Am J Roentgenol; 2021 Feb; 216(2):421-427. PubMed ID: 33325735
[No Abstract] [Full Text] [Related]
20. A stable prostacyclin analogue (iloprost) in the treatment of Buerger's disease: a prospective analysis of 150 patients.
Bozkurt AK; Cengiz K; Arslan C; Mine DY; Oner S; Deniz DB; Ufuk D
Ann Thorac Cardiovasc Surg; 2013; 19(2):120-5. PubMed ID: 22971807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
